Oncology & Cancer
Discovery of key gene offers new hope in treating chronic myeloid leukemia
A key gene that could enhance the treatment success rates of chronic myeloid leukemia (CML) has been discovered by researchers.
Oct 7, 2024
0
34
Leukemia
Oncology & Cancer
Blood cancers: Expert explains what you need to know
Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.
Sep 30, 2024
0
0
Oncology & Cancer
Disparities found for Non-Hispanic Black patients in hematopoietic cell transplantation use for hematologic cancers
Non-Hispanic Black patients in the United States appear to have persistent disparities in terms of hematopoietic cell transplantation (HCT) for various hematologic cancers, according to a study published online Sept. 18 in ...
Sep 27, 2024
0
0
Oncology & Cancer
Treatment-free remission for chronic myeloid leukemia
Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. ...
Sep 26, 2024
0
0
Genetics
Study reveals why children with Down syndrome have higher risk of leukemia
People with Down syndrome face a higher risk of developing leukemia. Now researchers from the University of Copenhagen and Stanford University explain why, by identifying specific changes in blood cells of people with Down ...
Sep 25, 2024
0
13
Oncology & Cancer
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL).
Sep 24, 2024
0
0
Oncology & Cancer
Measurable residual disease results after consolidation therapy predictive of relapse in pediatric leukemia
For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements, according to a study published ...
Sep 24, 2024
0
0
Medical research
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemia
Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor (TKI) treatment for patients with chronic-phase chronic myeloid leukemia (CP-CML) significantly increased ...
Sep 23, 2024
0
0
Oncology & Cancer
Three facts about acute lymphocytic leukemia in children
September is Childhood Cancer Awareness Month. The most common type of childhood cancer is acute lymphocytic leukemia (ALL), a blood and bone marrow cancer that creates immature white blood cells that can't perform their ...
Sep 23, 2024
0
0
Oncology & Cancer
Novel treatment regimen yields promising response in advanced-phase chronic myeloid leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML)—including both accelerated or ...
Sep 18, 2024
0
7
